By Sneha S K (Reuters) - Eli Lilly said on Tuesday it will invest $5 billion to build a manufacturing facility in Virginia, part of the drugmaker's broader $27 billion plan to build four facilities across the United States over the next five years. The investment marks Lilly's latest push to boost domestic drug production and hedge against potential tariffs. Global pharmaceutical companies have been increasing U.S. investment to bolster manufacturing capacity after President Donald Trump urged the indus ...